← Back to directory

István Láng

Researcher Next ID · RN-011712

Researcher · Biochemistry, Genetics and Molecular Biology

University of Uyo

, Nigeria

Not currently recruitingFunding unknown
Works count
153
Citation count
19,142
H-index
44
i10-index
77

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Breast Cancer Treatment Studies
Cancer Treatment and Pharmacology
Advanced Breast Cancer Therapies
HER2/EGFR in Cancer Research
Colorectal Cancer Treatments and Studies

Publications

  • Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer

    New England Journal of Medicine · 2017 · 10.1056/nejmoa1703643

  • Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

    The Lancet · 2015 · 10.1016/s0140-6736(15)00986-1

  • Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status

    Journal of Clinical Oncology · 2011 · 10.1200/jco.2010.33.5091

  • Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98

    Journal of Clinical Oncology · 2007 · 10.1200/jco.2006.08.8617

  • Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

    New England Journal of Medicine · 2005 · 10.1056/nejmoa052306

Current projects

    No projects listed.